OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract 5417: The identification of BMS-595, an orally active imidazo[1,2-b]pyridazine CK2 inhibitor with in vivo anti-tumor activity

HTML

Year: 2015
Type: conference-abstract
Source: Cancer Research
DOI: 10.1158/1538-7445.am2015-5417
Authors: Christine M. Tarby, Liqi He, Brian E. Fink, Andrew Nation, Yufen Zhao, Soong-Hoon Kim, Libing Chen, John S. Tokarski, Chiang Yu, Jonathan G. Pabalan, Urvashi V. Roongta, Jonathan Lippy, Mary Obermeier, Paul A. Elzinga, Aberra Fura, Benjamin Henley, Joseph J. Fargnoli, William R. Foster, Ashvinikumar V. Gavai, Tai W. Wong, John T. Hunt, Gregory D. Vite, Ashok V. Purandare, Brent A. Rupnow
Institution: Bristol-Myers Squibb (United States)
Language: English

Topic: Cancer Mechanisms and Therapy
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: CK2 inhibitors, imidazo[1,2-b]pyridazines, CDK2, ATP-competitive kinase inhibitors, structure-activity relationship, oral bioavailability, tumor xenografts, anticancer activity, cancer therapeutics, kinase inhibitor discovery, anticancer drug development, oncogenic transcription factor
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2566720522
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security